Inmune Bio, Inc.
Clinical trials sponsored by Inmune Bio, Inc., explained in plain language.
-
New drug targets brain inflammation in early Alzheimer's patients
Disease control CompletedThis Phase 2 study tested whether XPro1595 could help people with early Alzheimer's disease who show signs of brain inflammation. The trial involved 208 participants aged 50-85 who received either the drug or a placebo for 24 weeks. Researchers measured changes in memory, thinkin…
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New immune cell therapy tested for Tough-to-Treat prostate cancer
Disease control CompletedThis early-stage study tested a new cell therapy called INKmune in men with advanced prostate cancer that had spread and stopped responding to standard hormone treatments. The main goals were to find the safest and most effective dose and to see how well patients tolerated the tr…
Phase: PHASE1, PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC